Stock Forecast

  Neovasc Inc. ( NVCN) Stock. Should you Buy or Sell?    $ 7.42

0.03 (0.40 %)



Neovasc Inc. Analysis

Updated on 10-09-2022
Symbol NVCN
Price $7.42
Beta 2.500
Volume Avg. $14.43 thousand
Market Cap $20.35 M
52 Week Range $4.59 - $21.5


Neovasc Inc. opened the day at $7.42 which is +'0.40 % on yesterday's close. Neovasc Inc. has a 52 week high of $21.5 and 52 week low of $4.59, which is a difference of $16.91. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $20.35 M and total net profit is $2547406 which means the company is trading at 7.99 times profit to market capitalization. Theoretically, if you were to buy Neovasc Inc. for $20.35 M, it would take 15 years to get your money back. Neovasc Inc. are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




Neovasc Inc. Stock Forecast - Is Neovasc Inc. a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreSell
ROA ScoreSell
DE ScoreNeutral
PE ScoreSell
PB ScoreBuy
Overall RecommendationNeutral

Growth and Value


PE Ratio -0.612
Dividend Yiel 0.000
Net Profit Margin -12.150


Valuing Neovasc Inc.


Price Book Value Ratio 0.460 Price To Book Ratio 0.460
Price To Sales Ratio 7.432 Price Earnings Ratio -0.612


How liquid is Neovasc Inc.


Current Ratio 12.879
Quick Ratio 12.241


Debt


Debt Ratio 0.271 Debt Equity Ratio 0.372
Long Term Debt To Capitalization 0.218 Total Debt To Capitalization 0.222



Latest news about Neovasc Inc.


Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference

VANCOUVER and MINNEAPOLIS, Aug. 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the H.C. Wainwright 24th Annual Global Investment Conference to be held September 12-14, 2022, in New York City. Neovasc's President and Chief Executive Officer, Fred Colen, will be presenting at 1:30 pm ET on Tuesday, September 13, 2022.

Date : 30/08/2022

Neovasc Inc. (NVCN) CEO Fred Colen on Q2 2022 Results - Earnings Call Transcript

Neovasc Inc. (NASDAQ:NVCN ) Q2 2022 Results Conference Call August 11, 2022 4:30 PM ET Company Participants Mike Cavanaugh - Investor Relations Fred Colen - President and Chief Executive Officer Chris Clark - Chief Financial Officer Conference Call Participants Vernon Bernardino - H. C. Wainwright Operator Greetings and welcome to Neovasc Inc Second Quarter 2022 Earnings Call.

Date : 11/08/2022

Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 8, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced that its management team will be participating in the 2022 Sidoti & Co. Summer Small Cap Virtual Investor Conference to be held June 15-16, 2022. Neovasc's Chief Operating Officer, Bill Little, will be presenting at 1:45 pm ET on Wednesday, June 15.The presentation can be accessed here. Additionally, a recording of the...

Date : 08/06/2022

Neovasc to Participate in H.C. Wainwright Global Investment Conference

VANCOUVER and MINNEAPOLIS, May 23, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire --  Neovasc, Inc.  (Neovasc or the Company) ( NASDAQ  ,  TSX  : NVCN) today announced that its management team will be participating in the H.C. Wainwright Global Investment Conference to be held May 23-26, 2022. Fred Colen, Neovasc's President and Chief Executive Officer, will be presenting at 11:00 am ET on Wednesday, May 25.

Date : 23/05/2022

Neovasc Inc. (NVCN) CEO Fred Colen on Q1 2022 Results - Earnings Call Transcript

Neovasc Inc. (NASDAQ:NVCN ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Mike Cavanaugh - Investor Relations Fred Colen - President and Chief Executive Officer Chris Clark - Chief Financial Officer Conference Call Participants Vernon Bernardino - H.C. Wainwright Operator Greetings and welcome to Neovasc First Quarter 2022 Earnings Conference Call.

Date : 12/05/2022





About Neovasc Inc.


CEO : Mr. Fred Colen
Sector : Healthcare
Industry : Medical Devices

Website : https://www.neovasc.com

Exchange : NASDAQ Capital Market

Description :

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.


My Newsletter

Sign Up For Updates & Newsletters